Quebec entrepreneur and former Mitacs intern Azadeh Dastmalchi developed a medical-grade smartwatch after struggling to find a device that could help her father monitor his hypertension. Now, in addition to targeting the one in three adults suffering from high blood pressure in North America, her company VitalTracer is pivoting its solution to assist with early detection and monitoring of COVID-19 symptoms.
Gum disease is a condition that shows up in 85 percent of cats and dogs before the age of four. Without proper treatment, the illness is painful and can lead to other health issues such as heart or kidney disease.
To improve the health of pets and prevent the issue, Quebec entrepreneur Andrée-Ann Adam has been working on a first-of-its-kind, all-natural dental gel.
Who could have foreseen that humanitarian activities during the 2010 earthquake in Haiti would, 10 years later, guide the way for researchers, entrepreneurs and Mitacs interns during the COVID-19 crisis?
During his deployment at a Red Cross field hospital after the earthquake, Dr. Abdo Shabah saw the potential for greater use of technology in emergency health interventions.
When Gurudeeban Selvaraj and Satyavani Kaliamurthi came to Canada in 2019, they had no idea they would be creating both a preventative vaccine and a curing drug to address the millennium’s biggest pandemic.
As of May 27, 2020, there have been 2,925,466 infected COVID-19 patients reported worldwide, with a total of 355,727 deaths. The rapid progression of the COVID-19 pandemic has raised concerns regarding the short supply of medical equipment needed to control the rate of transmission and mortality. In most developing countries, transporting vaccines can be difficult without the proper storage technologies, since vaccines and equipment can spoil in high temperatures.
According to the Public Health Agency of Canada, the total number of COVID-19 cases reached a high of 71,486 as of May 13, 2020 — with Ontario and Quebec collectively accounting for 83% of all cases and 92% of the Canadian death toll. With a mortality rate of 3.4%, COVID-19 has created an unprecedented — and growing — demand for a vaccine.
Near downtown Montréal, the Little Burgundy neighbourhood reveals many contrasts. In the south, it touches the Lachine Canal, a beautiful 14-kilometre cycling and pedestrian pathway that sees millions of visitors every year. In the north, it is bordered by the busy and grey Ville-Marie Expressway. One of the most multicultural communities in the city, Little Burgundy is home to upscale restaurants and boutiques, but also to a vulnerable population that struggles with food insecurity.
Professor Isabel Desgagné-Penix and her team at the Université du Québec à Trois-Rivières are the first to demonstrate that cannabinoids can be successfully grown in microalgae by a process called metabolic engineering.
The process of metabolic engineering extracts the genes responsible for cannabinoid production from cannabis plants and inserts them into algae, creating a type of cannabis surrogacy in algae.
Semah Aissaoui’s journey with Mitacs began in summer 2018 as an undergraduate in Tunisia when he first came to Canada as a Globalink research intern. He progressed on to receive the Mitacs Globalink Graduate Fellowship and attend graduate school at Polytechnique Montréal in Canada with the award. He now works with Fluent.ai on a Mitacs Accelerate award, researching how to remove background noise and reverberation from sound signals to enhance the accuracy of offline voice-activated devices.